Pfizer Zeldox Approval Awaits QTc Comparison To Risperdal, Zyprexa
Pfizer will compare the QTc interval prolongation of its antipsychotic Zeldox to Lilly's Zyprexa (olanzapine) and Janssen's Risperdal (risperidone) as a condition for approval.
Pfizer will compare the QTc interval prolongation of its antipsychotic Zeldox to Lilly's Zyprexa (olanzapine) and Janssen's Risperdal (risperidone) as a condition for approval.